Skip Navigation

Faculty Directory

Emma Beth McGinty, PhD

  • Professor

Departmental Affiliations

Center & Institute Affiliations

Contact Information

624 N. Broadway
Hampton House 359
Baltimore, Maryland 21205


View Current Courses


PhD, Johns Hopkins Bloomberg School of Public Health, 2013
MS, Columbia University Teachers College, 2006
BA, West Chester University, 2004
BS, West Chester University, 2004


Dr. McGinty’s research focuses on evaluation of mental health and substance use policies. Her interests include the evaluation of policies designed to better integrate behavioral, somatic, and social services for people with serious mental illness; study of policy approaches to addressing the U.S. opioid epidemic; and evaluation of policy issues at the intersection of mental illness, substance use, and violence.

In close concert with her policy evaluation research, Dr. McGinty conducts implementation research focused on developing strategies for wide-spread scale up of effective health and social services for people with mental illness or substance use disorders. She also conducts communication research examining how communication strategies influence public stigma toward, and support for policies that benefit, people with mental health or substance use conditions.

At Johns Hopkins, Dr. McGinty is the Co-Director of the Center for Mental Health and Addiction Policy Research and the Associate Director of the ALACRITY Center for Health and Longevity in Mental Illness. She completed her PhD in Health and Public Policy from the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health in 2013 and was awarded a MS in Health and Behavior Studies from Columbia University in 2006.

Honors and Awards

NIMH Implementation Research Institute (IRI) Fellow, 2017-2019

Maryland Healthcare Commission Research Fellow, 2011-2013

Johns Hopkins Bloomberg School of Public Health Sommer Scholar, 2009-2013

  • mental illness
  • substance use
  • violence
  • disability policy
  • social policy

Recent publications:

  • McGinty EE, Tormohlen KN, Barry CL, Bicket MC, Rutkow L, Stuart EA (2021). Mixed-methods study of how implementation of U.S. state medical cannabis laws affects treatment of chronic non-cancer pain and adverse opioid outcomes. Implementation Science, 16(1): 1-13.
  • McGinty EE, Presskreischer R, Anderson KE, Han H, Barry CL (2020). Psychological distress and COVID-19 related stressors reported in a longitudinal cohort of U.S. adults in April and July 2020. Journal of the American Medical Association (JAMA), 324(24): 2555-2557.
  • McGinty EE, Murphy KA, Dalcin AT, Stuart EA, Wang NY, Dickerson F, Gudzune K, Jerome G, Thompson D, Cullen BA, Gennusa J, Kilbourne AM, Daumit GL (2020). A Model for Advancing Scale-Up of Complex Interventions for Vulnerable Populations: The ALACRITY Center for Health and Longevity in Mental Illness. Journal of General Internal Medicine, 36(2) 500-505.
  • McGinty EE, Barry CL (2020). Stigma Reduction to Combat the Addiction Crisis — Developing an Evidence Base. New England Journal of Medicine, 382 (14), 1291-1292.
  • McGinty EE, Daumit GL (2020). Integrating Mental Health and Addiction Treatment into General Medical Care: The Role of Policy. Psychiatric Services, 71(11), 1163-1169. *Keynote paper for ‘Caring for People with Mental Health and Substance Use Disorders in Primary Care Settings: A Workshop of the Forum of Mental Health and Substance Use Disorders of the National Academies of Science, Engineering, and Medicine,’ June 2020.